Growth Metrics

Adaptive Biotechnologies (ADPT) Other Non-Current Liabilities (2019 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Other Non-Current Liabilities for 6 consecutive years, with $20000.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities changed 0.0% to $20000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20000.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $20000.0 for FY2025, 0.0% changed from the prior year.
  • Other Non-Current Liabilities hit $20000.0 in Q4 2025 for Adaptive Biotechnologies, roughly flat from $20000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $128.2 million in Q2 2023 to a low of $20000.0 in Q2 2024.
  • Historically, Other Non-Current Liabilities has averaged $45.9 million across 4 years, with a median of $20000.0 in 2024.
  • Biggest five-year swings in Other Non-Current Liabilities: crashed 99.98% in 2024 and later changed 0.0% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $125.4 million in 2022, then grew by 2.24% to $128.2 million in 2023, then plummeted by 99.98% to $20000.0 in 2024, then changed by 0.0% to $20000.0 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for ADPT at $20000.0 in Q4 2025, $20000.0 in Q3 2025, and $20000.0 in Q2 2025.